Patents by Inventor Weihong Wen

Weihong Wen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF
    Publication number: 20250236680
    Abstract: PSMA is a prostate cancer marker, and cancers with higher malignancy or metastasis, or resistant to androgen deprivation therapy, usually express much higher PSMA. The present invention relates to the improved anti-PSMA antibodies or antigen-binding fragments thereof, related nucleic acids, vectors, cells, compositions, kits, and the methods of use thereof.
    Type: Application
    Filed: March 28, 2023
    Publication date: July 24, 2025
    Applicant: Xi An OriMAb Biotechnology Company Ltd.
    Inventors: Aizhi Zhao, Weihong Wen
  • Anti-PSMA antibodies and use thereof
    Patent number: 11414497
    Abstract: The present invention relates to compositions and methods related to antibody or antibody fragments that specifically bind PSMA.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: August 16, 2022
    Assignee: OriMabs Ltd.
    Inventors: Aizhi Zhao, Weihong Wen, Yueheng Han
  • Anti-PSMA Antibodies and Use Thereof
    Publication number: 20210277141
    Abstract: The present invention relates to compositions and methods related to antibody or antibody fragments that specifically bind PSMA.
    Type: Application
    Filed: April 13, 2017
    Publication date: September 9, 2021
    Applicant: ORIMABS LTD.
    Inventors: Aizhi Zhao, Weihong Wen, Yueheng Han